SRX Global Inc. SRXH

Consumer staples SIC 2080 - Beverages NAICS Manufacturing › Beverage and Tobacco Product Manufacturing › Beverage Manufacturing derived NYSE

Health Solutions Inc. ("SRx" or the "Company") is the successor reporting entity following a reverse merger with

Better Choice Company, Inc. ("Better Choice" or "BTTR"), the pet health and wellness business.

SRx was engaged in specialty pharmaceuticals and healthcare services, including a series of acquisitions to expand its operations. These

legacy operations faced financial difficulties and subsequently filed for bankruptcy, resulting in the winding down of the majority of

Last close 1.07 2026-10-23
Market cap $21.7M 2026-06-30 share count
52-week range 0.96 - 42.61

Valuation FY2025 figures against the last close

P/S3.3x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-2.13

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $6.5M$2.0M$38.6M$54.7M$46.0M$42.6M$15.6M$14.8M$1.7K$48
Cost of revenue $5.0M$22.0M$26.8M$39.4M$30.6M$26.5M$9.7M$7.5M$334$5
Gross profit $1.5M$13.0M$11.8M$15.3M$15.4M$16.1M$5.9M$7.3M$1.4K$43
R&D —$100.0K$100.0K$500.0K$500.0K$100.0K————
SG&A $12.9M$19.0M$24.4M$35.4M$28.5M$34.5M$19.8M$6.1M$525.4K$132.2K
Total operating expenses $12.9M$19.0M$33.0M$54.0M$32.6M$43.4M$42.2M$12.5M$525.4K$459.7K
Operating income -$11.4M-$6.0M-$21.2M-$38.8M-$17.3M-$27.3M-$36.3M-$5.2M-$524.0K-$459.7K
Interest expense $628.0K$467.0K$1.4M$551.0K$3.2M$9.2M$670.0K$868.0K$780.3K$412.0K
Pre-tax income -$8.6M-$159.0K-$22.8M-$39.3M$3.4M-$59.3M-$184.5M-$1.1M-$1.7M-$933.8K
Income tax —$1.2M$267.0K$18.0K$37.0K$0$0$0$0$0
Net income -$45.0M-$43.1M-$22.8M-$39.3M$3.4M-$59.3M-$184.5M-$6.0M-$1.7M-$933.8K
EPS, basic -2.13-1.95-32.29-58.930.15-7.26——-0.02-0.01
EPS, diluted -2.13-1.95-32.29-58.930.14-7.26-5.55-0.52-0.58-0.01
Shares, diluted (wtd. avg.) 21.1M22.1M12.4M667,11421.9M8.2M—3.0M3.0M70.5M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $1.3M$106.0K$4.5M$9.5M$28.9M$4.0M$2.5M$3.9M$157.0K$10.2K
Receivables $3.9M$9.3M$4.4M$6.7M$6.8M$4.6M$5.8M$116.0K$0$45
Inventory $2.1M$3.4M$6.6M$10.3M$5.2M$4.9M$6.6M$1.6M$14.9K$6.4K
Total current assets $8.1M$13.6M$16.2M$27.5M$43.9M$17.6M$17.6M$5.9M$16.3K$16.6K
Property, plant and equipment $88.0K$6.0M$230.0K$375.0K$369.0K$252.0K$417.0K$71.0K$0$0
Goodwill —$405.0K$18.3M$0$18.6M$18.6M$18.6M$0——
Other intangibles —$7.0M—$10.1M$11.6M$13.1M$14.6M$0——
Total assets $8.4M$33.8M$16.7M$38.7M$74.7M$51.3M$53.5M$6.0M$16.3K$16.6K
Accounts payable $2.1M$39.8M$6.9M$2.9M$4.6M$3.1M$4.0M$765.0K$106.7K$28.4K
Short-term debt —$31.6M$4.6M$165.0K$855.0K$8.0M$20.9M$0$554.0K—
Total current liabilities $3.5M$81.3M$13.7M$5.6M$7.3M$54.6M$33.0M$9.0M$1.2M$591.0K
Long-term debt —$696.0K$4.6M$11.4M$9.4M$24.6M$16.4M$6.2M$0—
Total liabilities $8.0M$88.9M$13.8M$17.1M$16.8M$79.4M$50.0M$9.0M——
Retained earnings -$22.9M-$70.0M-$321.3M-$298.6M-$259.3M-$260.6M-$201.3M-$16.7M-$3.1M-$1.4M
Total equity $407.0K-$55.1M-$33.8M$21.5M$57.9M-$28.1M-$7.1M-$3.0M-$2.1M-$574.3K

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$8.1M-$1.5M$97.0K-$20.6M-$11.9M-$7.5M-$21.0M-$6.9M-$39.8K-$180.6K
Depreciation and amortisation $100.0K$100.0K$200.0K$200.0K$100.0K$200.0K$100.0K—$0$2.2K
Stock-based compensation $3.2M$3.7M$1.8M$3.0M$4.1M$8.9M$10.3M$431.0K——
Capital expenditure —$41.0K$18.0K$198.0K$353.0K$151.0K$110.0K$31.0K$0$250.0K
Investing cash flow $5.9M-$1.1M-$18.0K-$198.0K-$353.0K-$151.0K-$20.2M-$31.0K$0-$250.0K
Financing cash flow $12.2M$932.0K-$5.1M$1.3M$37.2M$9.1M$39.8M$10.7M$31.0K$440.8K
Buybacks ———$0$1.6M$0—$0$0—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-021307.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -200M -100M 0 100M Revenue, FY2016: 48 Gross profit, FY2016: 43 Net income, FY2016: -933.8K Revenue, FY2017: 1.7K Gross profit, FY2017: 1.4K Net income, FY2017: -1.7M Revenue, FY2018: 14.8M Gross profit, FY2018: 7.3M Net income, FY2018: -6M Revenue, FY2019: 15.6M Gross profit, FY2019: 5.9M Net income, FY2019: -184.5M Revenue, FY2020: 42.6M Gross profit, FY2020: 16.1M Net income, FY2020: -59.3M Revenue, FY2021: 46M Gross profit, FY2021: 15.4M Net income, FY2021: 3.4M Revenue, FY2022: 54.7M Gross profit, FY2022: 15.3M Net income, FY2022: -39.3M Revenue, FY2023: 38.6M Gross profit, FY2023: 11.8M Net income, FY2023: -22.8M Revenue, FY2024: 2M Gross profit, FY2024: 13M Net income, FY2024: -43.1M Revenue, FY2025: 6.5M Gross profit, FY2025: 1.5M Net income, FY2025: -45M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $48 $1.7K $14.8M $15.6M $42.6M $46.0M $54.7M $38.6M $2.0M $6.5M
Gross profit $43 $1.4K $7.3M $5.9M $16.1M $15.4M $15.3M $11.8M $13.0M $1.5M
Net income -$933.8K -$1.7M -$6.0M -$184.5M -$59.3M $3.4M -$39.3M -$22.8M -$43.1M -$45.0M

Recent filings and events

  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Material agreement signed Item 1.01
  • Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Unregistered share sale Item 3.02
  • Unregistered share sale Item 3.02
  • Material agreement signed Item 1.01
  • Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Delisting notice Item 3.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2080

TickerCompanyMarket capP/ERevenue growth
KO COCA COLA CO $398.88B 30.5x 1.9%
PEP PEPSICO INC $185.31B 22.6x 2.3%
KDP Keurig Dr Pepper Inc. $47.19B 22.7x 8.2%
BF-B BROWN FORMAN CORP $13.49B 19.2x -1.2%
PRMB Primo Brands Corp $7.13B 123.1x 29.3%
COCO Vita Coco Company, Inc. $3.24B 47.5x 18.2%
BRCC BRC Inc. $1.33B — 1.7%
WEST Westrock Coffee Co $964.1M — 39.8%